Close Menu

The UK's National Health Service needs to form some kind of committee to evaluate the potential of diagnostic tests in order to take full advantage of advances in genomic medicine, says the Times Online's Mark Henderson. Two science think tanks at the University of Cambridge warn that "the potential of genetic testing to deliver better treatments at lower cost will be delayed unless there is a system to establish the benefits," Henderson says.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

AstraZeneca has released its coronavirus vaccine trial protocol, according to the New York Times.

Time magazine looks into how liquid biopsies are changing cancer care.

According to the Guardian, more than 150 countries have signed on to a global SARS-CoV-2 vaccine plan.

In PNAS this week: similar muscle protein patterns across hypertrophic cardiomyopathy phenotypes, analysis of gene expression and brain anatomy in major depression, and more.